N. Yamamoto

Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial.

M. Satouchi, Y. Fujisaka, Y. Okuma, 2024, Lung cancer.

Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study.

M. Sugeno, T. Kawata, Shunsuke Kondo, 2024, Cancer treatment and research communications.

Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital

T. Shimoi, K. Yonemori, T. Koyama, 2023, JAMA network open.